Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Feb 14, 2014 · 10-Q · 45 days after period end · 0001354488-14-000725
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | $26.40K | -$387.75K | -$2.71M | -$411.31K |
| EPS Diluted | $0.00 | -$0.02 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Feb 14, 2014 · 45 d after period end
